Services

Professional and Cost-Saving Solutions

Real-Time and Accelerated Stability Testing

Creative Enzymes provides high-quality services that help to develop applications of various enzymes. Noticing the enzyme stability is an important property in its application, Creative Enzymes has set up services targeted at improvement in stabilization. In addition, we also provide reliable stability testing under various storage conditions. Our stability testing services deliver scientifically rigorous data packages that support IND/NDA filings, diagnostic kit registrations, and industrial process validation, ensuring your enzyme products meet stringent quality and regulatory requirements throughout their lifecycle.

Schematic illustration of real-time and accelerated stability testing approaches for enzyme products

Background: Understanding Enzyme Stability Testing

Enzyme stability represents a fundamental determinant of product efficacy, safety, and commercial viability across biopharmaceutical, diagnostic, and industrial applications. Enzyme stability test is usually built on the foundation of data which are collected from experimental protocols. As for enzymes, the bio-activity is influenced by many factors, therefore, the stabilization test is essential. Stabilization test can be divided into two types, real-time and accelerated stabilization testing respectively.

Real-time stability testing involves long-term storage of enzyme products under recommended storage conditions (typically 2-8°C, -20°C, or -80°C for frozen products) with periodic evaluation of critical quality attributes (CQAs) over the intended shelf life. This approach provides the most accurate determination of actual storage stability but requires extended timelines proportional to the claimed shelf life. Accelerated stability testing, conversely, subjects enzymes to elevated stress conditions (increased temperature, humidity, light exposure, or mechanical agitation) to induce accelerated degradation, enabling rapid identification of stability liabilities, comparison of formulation candidates, and prediction of long-term stability trends through Arrhenius modeling or other kinetic extrapolation methods.

Unlike small-molecule drugs, protein-based enzymes are susceptible to diverse degradation pathways including chemical modifications, physical instabilities, and biological contamination. Comprehensive stability characterization is essential to establish appropriate storage conditions and define shelf-life specifications. We offer a wide range of test conditions from -20 °C to 95 °C, utilizing Design of Experiment (DOE) matrix to screen up to 48 conditions at once, validated stability kinetic models, and generation of both predicted and actual shelf-life data.

What We Offer: Comprehensive Stability Testing Services

Creative Enzymes provides integrated real-time and accelerated stability testing services designed to meet diverse regulatory, technical, and timeline requirements across pharmaceutical, diagnostic, and industrial applications. Our offerings encompass complete stability protocol design, execution, analytical testing, and regulatory-compliant documentation.

Specialized Modules Information
Pre-Study Assessment and Method Validation We offer comprehensive pre-stability assessment services to characterize enzyme physicochemical properties, identify critical quality attributes, and select stability-indicating methods. This module includes forced degradation studies under thermal, oxidative, pH, and light stress to determine degradation pathways and establish analytical methods capable of monitoring relevant stability parameters with appropriate specificity and sensitivity. Inquiry
Real-Time Stability Testing of Enzymes Our real-time stability testing services provide definitive shelf-life determination under intended storage conditions following ICH Q1A(R2) guidelines. We design and execute long-term stability protocols with defined pull points, storage in validated chambers (2-8°C, -20°C, -80°C, or controlled ambient), and comprehensive analytical characterization including activity, purity, and structural integrity assessments to support regulatory filings and product registrations. Inquiry
Accelerated Stability Testing of Enzymes Accelerated stability testing employs elevated temperature (25°C, 30°C, 40°C) and humidity stress (60% RH, 75% RH) to rapidly evaluate formulation robustness, establish preliminary shelf-life estimates, and support clinical phase development when real-time data is unavailable. Our services include protocol design stressing relevant degradation mechanisms, kinetic analysis using Arrhenius equations, and correlation studies to validate accelerated-to-real-time stability predictions. Inquiry
Stability Data Analysis and Shelf-Life Modeling for Enzymes We provide expert statistical analysis and regulatory-compliant reporting of stability data, including trend analysis, shelf-life determination using linear regression or nonlinear models, pooling analysis across batches, and bracketing/matrixing justifications. Our deliverables include comprehensive stability reports suitable for regulatory submissions, with statistical evaluation of data variability, out-of-trend investigation, and establishment of acceptance criteria for commercial release. Inquiry

Service Workflow

Workflow of real-time and accelerated stability testing service

Service Details

Creative Enzymes employs ICH-compliant stability testing protocols with cGMP-qualified equipment and validated analytical methods. Our capabilities include:

  • ICH Q1A(R2) and Q5C compliant long-term, intermediate, and accelerated stability storage
  • DOE matrix screening up to 48 conditions simultaneously from -20°C to 95°C
  • Forced degradation studies (thermal, oxidative, photolytic, hydrolytic) to establish degradation pathways
  • Stability-indicating method validation (activity assays, SEC-HPLC, RP-HPLC, CE-SDS)
  • Validated stability chambers with continuous monitoring (±2°C temperature control)
  • Statistical analysis and kinetic modeling for shelf-life prediction and determination

Contact Our Team

Why Choose Us: Key Advantages of Creative Enzymes

Regulatory Compliance

ICH, FDA, and EMA compliant stability protocols with cGMP documentation and quality oversight for seamless regulatory submissions.

Customized Study Design

Tailored stability protocols addressing specific degradation pathways, formulation sensitivities, and regulatory pathway requirements.

Advanced Analytical Platforms

State-of-the-art instrumentation for activity, purity, and structural analysis with validated stability-indicating methods.

Comprehensive Data Packages

Statistical analysis, kinetic modeling, and regulatory-ready reports supporting global registration requirements.

Flexible Scale and Timeline

Scalable services from early-stage formulation screening through commercial annual batch monitoring with expedited options.

Expert Scientific Support

Dedicated stability scientists providing protocol consultation, deviation investigation, and regulatory strategy alignment.

Case Studies and Real-World Insights

Case 1: Long-Term Real-Time Stability Study for Therapeutic Enzyme

A client developing a recombinant therapeutic enzyme for lysosomal storage disorder treatment required a comprehensive 36-month real-time stability study to support their Biologics License Application (BLA). The enzyme, formulated as a lyophilized powder for intravenous administration, required strict storage at 2-8°C with demonstrated stability across multiple manufacturing batches. Creative Enzymes designed and executed a cGMP-compliant stability protocol with testing intervals at 0, 3, 6, 9, 12, 18, 24, and 36 months. Critical quality attributes included catalytic activity (specific activity assay), purity (SEC-HPLC, RP-HPLC), subunit integrity (SDS-PAGE), and particulate matter (light obscuration). The study demonstrated excellent stability with less than 5% activity loss and no significant aggregation over 36 months, supporting a 24-month shelf-life claim approved by regulatory authorities. The comprehensive data package included statistical trend analysis, outlier evaluation, and establishment of acceptance criteria that formed the basis for the product's commercial release specifications.

Case 2: Accelerated Stability Testing for Diagnostic Enzyme Formulation Screening

A diagnostic manufacturer required rapid evaluation of three candidate formulations for a horseradish peroxidase (HRP)-based detection reagent to determine optimal buffer composition and stabilizer selection for claimed 18-month shelf life at 2-8°C. Rather than waiting 18 months for real-time data, Creative Enzymes implemented an accelerated stability protocol using elevated temperatures (25°C, 30°C, 37°C) over 3 months to predict long-term stability. Enzyme activity was monitored weekly using chromogenic substrate assay, while aggregation was tracked by turbidimetry and SEC-HPLC. Arrhenius analysis of the degradation kinetics revealed that Formulation C, containing trehalose and proprietary stabilizers, exhibited activation energy consistent with stable storage and predicted less than 10% activity loss at 18 months. In contrast, Formulations A and B showed significant aggregation at 37°C within 4 weeks, predicting unacceptable shelf life. The accelerated data allowed the client to advance Formulation C to formal stability studies 12 months ahead of traditional timelines, significantly accelerating their product development cycle and market entry.

Frequently Asked Questions (FAQs): Stability Testing

  • Q: What is the difference between real-time and accelerated stability testing?

    A: Real-time testing evaluates products under labeled storage conditions over their full shelf life. Accelerated testing uses elevated temperatures to speed degradation, enabling rapid screening and preliminary shelf-life estimation. Real-time data is required for final claims, while accelerated testing supports early decisions.
  • Q: How long does a stability study typically take?

    A: Real-time studies typically last 12–36 months with scheduled intervals. Accelerated studies usually take 3–6 months, while stress studies can generate preliminary data within 4–8 weeks.
  • Q: What sample quantities are required for stability testing?

    A: Requirements depend on study design, but typically 100–200 mg per condition is sufficient. We optimize protocols to minimize material use and support limited-sample strategies when needed.
  • Q: Do your stability studies comply with FDA and EMA regulatory requirements?

    A: Yes, studies follow ICH guidelines and cGMP standards, with full regulatory documentation suitable for IND, NDA, BLA, and marketing submissions.
  • Q: Can you predict shelf life from accelerated stability data?

    A: Yes, using kinetic modeling (e.g., Arrhenius), but predictions must be confirmed with real-time data for regulatory approval.
  • Q: What analytical methods do you use for stability-indicating testing?

    A: We use activity assays, chromatography (SEC, RP-HPLC), electrophoresis, spectroscopy (CD, DSC), and mass spectrometry, all validated for stability indication.
  • Q: Do you support in-use stability and freeze-thaw studies?

    A: Yes, we evaluate stability under handling conditions, including repeated use and freeze-thaw cycles, tailored to real-world applications.
  • Q: How do you handle out-of-specification (OOS) or out-of-trend (OOT) results?

    A: OOS/OOT results trigger immediate investigation, root cause analysis, and CAPA actions, with rapid client notification and full documentation.
  • Q: Can you support stability studies for contract manufacturing transfers?

    A: Yes, we design comparability studies for process or site changes, including statistical evaluation and ongoing stability programs.
  • Q: What deliverables are provided upon study completion?

    A: We provide comprehensive reports with data, analysis, and conclusions, plus eCTD-ready documentation and interim updates for ongoing studies.

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.